Inuvo Posts 25% Growth in the Second Quarter 2025
Inuvo (NYSE American: INUV) reported strong financial results for Q2 2025, with net revenue increasing 25% to $22.7 million compared to Q2 2024. The AI AdTech solutions provider demonstrated significant growth in the first half of 2025, with a 40% revenue increase to $49.4 million.
Key Q2 metrics include gross profit growth of 12% to $17.1 million, improved Adjusted EBITDA loss of $0.6 million (from $0.7 million), and a narrowed net loss of $1.5 million ($0.10 per share). The company maintains a strong financial position with $2.1 million in cash and an unused $10 million working capital facility with no debt.
Inuvo (NYSE American: INUV) ha riportato risultati finanziari solidi per il secondo trimestre 2025, con un fatturato netto in crescita del 25% a 22,7 milioni di dollari rispetto al secondo trimestre 2024. Il fornitore di soluzioni AI AdTech ha mostrato una crescita significativa nella prima metà del 2025, con un aumento del fatturato del 40% a 49,4 milioni di dollari.
I principali indicatori del secondo trimestre includono una crescita del margine lordo del 12% a 17,1 milioni di dollari, una riduzione della perdita Adjusted EBITDA a 0,6 milioni di dollari (da 0,7 milioni) e una perdita netta ridotta a 1,5 milioni di dollari (0,10 dollari per azione). L'azienda mantiene una solida posizione finanziaria con 2,1 milioni di dollari in contanti e una linea di credito per capitale circolante inutilizzata di 10 milioni di dollari, senza debiti.
Inuvo (NYSE American: INUV) reportó sólidos resultados financieros para el segundo trimestre de 2025, con ingresos netos que aumentaron un 25% hasta 22,7 millones de dólares en comparación con el segundo trimestre de 2024. El proveedor de soluciones AI AdTech mostró un crecimiento significativo en la primera mitad de 2025, con un aumento del 40% en ingresos hasta 49,4 millones de dólares.
Los principales indicadores del segundo trimestre incluyen un crecimiento del beneficio bruto del 12% hasta 17,1 millones de dólares, una mejora en la pérdida de EBITDA ajustado a 0,6 millones de dólares (desde 0,7 millones) y una reducción en la pérdida neta a 1,5 millones de dólares (0,10 dólares por acción). La empresa mantiene una sólida posición financiera con 2,1 millones de dólares en efectivo y una línea de capital de trabajo no utilizada de 10 millones de dólares, sin deuda.
Inuvo (NYSE American: INUV)는 2025년 2분기에 강력한 재무 실적을 보고했으며, 2024년 2분기 대비 순매출이 25% 증가한 2,270만 달러를 기록했습니다. AI 광고기술 솔루션 제공업체인 이 회사는 2025년 상반기에 매출이 40% 증가해 4,940만 달러를 달성하며 큰 성장을 보였습니다.
2분기 주요 지표로는 12% 증가한 1,710만 달러의 총이익, 조정 EBITDA 손실이 70만 달러에서 60만 달러로 개선, 그리고 순손실이
Inuvo (NYSE American : INUV) a annoncé des résultats financiers solides pour le deuxième trimestre 2025, avec un chiffre d'affaires net en hausse de 25 % à 22,7 millions de dollars par rapport au deuxième trimestre 2024. Le fournisseur de solutions AI AdTech a connu une croissance significative au premier semestre 2025, avec une augmentation de 40 % du chiffre d'affaires à 49,4 millions de dollars.
Les principaux indicateurs du deuxième trimestre incluent une croissance du bénéfice brut de 12 % à 17,1 millions de dollars, une amélioration de la perte d'EBITDA ajusté à 0,6 million de dollars (contre 0,7 million), et une réduction de la perte nette à 1,5 million de dollars (0,10 dollar par action). L'entreprise maintient une solide position financière avec 2,1 millions de dollars en liquidités et une facilité de fonds de roulement inutilisée de 10 millions de dollars, sans dette.
Inuvo (NYSE American: INUV) meldete starke Finanzergebnisse für das zweite Quartal 2025, mit einem Nettoumsatzanstieg von 25 % auf 22,7 Millionen US-Dollar im Vergleich zum zweiten Quartal 2024. Der Anbieter von AI AdTech-Lösungen verzeichnete im ersten Halbjahr 2025 ein signifikantes Wachstum mit einem Umsatzanstieg von 40 % auf 49,4 Millionen US-Dollar.
Wichtige Kennzahlen für das zweite Quartal umfassen ein Bruttogewinnwachstum von 12 % auf 17,1 Millionen US-Dollar, eine verbesserte Adjusted EBITDA-Verlust von 0,6 Millionen US-Dollar (von 0,7 Millionen) und einen verringerten Nettoverlust von 1,5 Millionen US-Dollar (0,10 US-Dollar pro Aktie). Das Unternehmen hält eine starke Finanzposition mit 2,1 Millionen US-Dollar in bar und einer ungenutzten 10 Millionen US-Dollar Betriebskapitalfazilität ohne Schulden.
- None.
- Gross margin declined to 75.4% from 84.0% year-over-year
- Operating expenses increased to $19.1M from $17.0M
- Continued net loss of $1.5M despite revenue growth
- Cash position relatively low at $2.1M
- Marketing costs increased to $14.1M from $12.4M
Insights
Inuvo shows strong 25% YoY growth with narrowing losses, but continues operating at a deficit despite five years of sustained growth.
Inuvo's Q2 2025 results demonstrate continued momentum with revenue up 25% to
The company's gross profit increased by
On the expense side, all operating cost categories increased year-over-year, with marketing costs rising to
The six-month results paint an even more positive picture with
Inuvo's balance sheet shows
Management to host conference call at 4:15 PM ET, Thursday, August 7, 2025
LITTLE ROCK, Ark., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, today announced its financial results for the second quarter and six-month period ended June 30, 2025.
Second Quarter 2025 Highlights Compared to Second Quarter 2024:
- Net revenue increased
25% to$22.7 million from$18.2 million - Gross profit increased
12% to$17.1 million - Adjusted EBITDA improved
14% to a loss of$0.6 million from a loss of$0.7 million - Net loss narrowed to
$1.5 from$1.7 million and$0.10 from$0.12 per share
Six-Month 2025 Highlights Compared to Six-Month 2024:
- Net revenue increased
40% to$49.4 million from$35.2 million - Gross profit increased
26% to$38.2 million from$30.2 million - Adjusted EBITDA improved
59% to a loss of$0.7 million from a loss of$1.7 million - Net loss narrowed to
$2.8 million from$3.9 million and$0.19 from$0.28 per share
Richard Howe, CEO of Inuvo, commented, “We're pleased to report another quarter of strong double-digit revenue growth. Our growth rate for the first half of 2025 was
Financial Results for the Second Quarter Ended June 30, 2025
Net revenue for the second quarter of 2025 totaled
Gross profit increased
Operating expenses were
Marketing costs were
Finance expenses, net of interest income, were
Other income was approximately
Net loss for the quarter was
Non-cash expenses including depreciation, amortization and stock-based compensation totaled
Adjusted EBITDA improved to a loss of
Liquidity and Capital Resources
As of June 30, 2025, Inuvo had
The Company continues to actively manage liquidity while investing in strategic growth initiatives.
Conference Call Details:
Date: Thursday, August 7, 2025
Time: 4:15 p.m. Eastern Time
Toll-free Dial-in Number: 1-800-717-1738
International Dial-in Number: 1- 646-307-1865
Conference ID: 1148531
Webcast Link: HERE
A telephone replay will be available through Thursday, August 21, 2025. To access the replay, please dial 1-844-512-2921 (domestic) or 1-412-317-6671 (international). At the system prompt, please enter the code 1148531 followed by the # sign. You will then be prompted for your name, company, and phone number. Playback will then automatically begin.
About Inuvo
Inuvo®, Inc. (NYSE American: INUV) is a market leader in Artificial Intelligence built for advertising. Its IntentKey® AI solution is a first-of-its-kind proprietary and patented technology capable of identifying and actioning to the reasons why consumers are interested in products, services, or brands, not who those consumers are. To learn more, visit www.inuvo.com.
Safe Harbor / Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Inuvo’s quarter-end financial close process and preparation of financial statements for the quarter that are subject to risks and uncertainties that could cause results to be materially different than expectations. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including, without limitation risks detailed from time to time in our filings with the Securities and Exchange Commission (the “SEC”), and represent our views only as of the date they are made and should not be relied upon as representing our views as of any subsequent date. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in Inuvo, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 as filed on February 27, 2025, and our other filings with the SEC. Additionally, forward looking statements are subject to certain risks, trends, and uncertainties including the continued impact of Covid-19 on Inuvo’s business and operations. Inuvo cannot provide assurances that the assumptions upon which these forward-looking statements are based will prove to have been correct. Should one of these risks materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those expressed or implied in any forward-looking statements, and investors are cautioned not to place undue reliance on these forward-looking statements, which are current only as of this date. Inuvo does not intend to update or revise any forward-looking statements made herein or any other forward-looking statements as a result of new information, future events or otherwise. Inuvo further expressly disclaims any written or oral statements made by a third party regarding the subject matter of this press release. The information which appears on our websites and our social media platforms is not part of this press release.
Investor Contact:
Wallace Ruiz
Chief Financial Officer
Tel (501) 205-8397
wallace.ruiz@inuvo.com
INUVO, INC. | ||||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||||
June 30 | June 30 | June 30 | June 30 | |||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||||
Net revenue | ||||||||||||||||||
Cost of revenue | 5,576,545 | 2,906,188 | 11,197,486 | 5,005,230 | ||||||||||||||
Gross profit | 17,094,788 | 15,302,817 | 38,181,879 | 30,227,552 | ||||||||||||||
Operating expenses: | ||||||||||||||||||
Marketing costs | 14,138,328 | 12,431,580 | 31,651,322 | 25,534,224 | ||||||||||||||
Compensation | 3,201,006 | 3,031,231 | 6,800,327 | 6,256,090 | ||||||||||||||
General and administrative | 1,799,011 | 1,539,393 | 3,543,574 | 2,227,903 | ||||||||||||||
Total operating expenses | 19,138,345 | 17,002,204 | 41,995,223 | 34,018,217 | ||||||||||||||
Operating loss | (2,043,557 | ) | (1,699,387 | ) | (3,813,344 | ) | (3,790,665 | ) | ||||||||||
Finance expense, net | 17,697 | 42,451 | 45,626 | 62,831 | ||||||||||||||
Other income | 559,991 | - | 1,100,562 | - | ||||||||||||||
Income tax expense | - | 5,353 | 2,676 | 5,353 | ||||||||||||||
Net loss | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
Net loss per share, basic and diluted | ||||||||||||||||||
Net loss income | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
Weighted average shares outstanding | ||||||||||||||||||
Basic | 14,450,640 | 14,011,853 | 14,361,782 | 13,945,396 | ||||||||||||||
Diluted | 14,450,640 | 14,011,853 | 14,361,782 | 13,945,396 |
INUVO, INC. | |||||||
CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||
June 30 | December 31 | ||||||
2025 | 2024 | ||||||
Assets | |||||||
Cash and cash equivalent | |||||||
Accounts receivable, net | 9,737,823 | 12,545,771 | |||||
Prepaid expenses and other current assets | 670,852 | 639,805 | |||||
Total current assets | 12,543,863 | 15,644,821 | |||||
Property and equipment, net | 1,755,495 | 1,792,903 | |||||
Goodwill | 9,853,342 | 9,853,342 | |||||
Intangible assets, net of accumulated amortization | 3,660,124 | 3,894,875 | |||||
Other assets | 876,224 | 1,009,990 | |||||
Total assets | |||||||
Liabilities and Stockholders’ Equity | |||||||
Current liabilities | |||||||
Accounts payable | |||||||
Accrued expenses and other current liabilities | 7,110,754 | 9,463,537 | |||||
Total current liabilities | 15,915,287 | 17,885,888 | |||||
Long-term liabilities | 694,122 | 835,271 | |||||
Total stockholders' equity | 12,079,639 | 13,474,772 | |||||
Total liabilities and stockholders' equity |
RECONCILIATION OF LOSS FROM NET LOSS TO ADJUSTED EBITDA | ||||||||||||||||
(unaudited) | ||||||||||||||||
Three Months Ended | Six Months Ended | |||||||||||||||
June 30 | June 30 | June 30 | June 30 | |||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||
Net loss | ) | ) | ) | ) | ||||||||||||
Interest Expense | 17,697 | 42,451 | 45,626 | 62,831 | ||||||||||||
Income tax Expense | - | 5,353 | 2,676 | 5,353 | ||||||||||||
Depreciation and amortization | 562,558 | 712,916 | 1,130,600 | 1,386,119 | ||||||||||||
EBITDA | (921,008 | ) | (986,471 | ) | (1,582,182 | ) | (2,404,546 | ) | ||||||||
Stock-based compensation | 291,789 | 318,681 | 596,073 | 714,993 | ||||||||||||
Non recurring items: | ||||||||||||||||
Employee Benefit | - | - | 335,000 | - | ||||||||||||
Adjusted EBITDA | ) | ) | ) | ) |
Reconciliation of Net Loss to EBITDA and Adjusted EBITDA
We present EBITDA and Adjusted EBITDA as a supplemental measure of our performance. We defined EBITDA as Net loss plus (i) interest expense, (ii) depreciation, and (iii) amortization. We further define Adjusted EBITDA as EBITDA plus (iv) stock-based compensation and (v) certain identified expenses that are not expected to recur or be representative of future ongoing operation of the business. These adjustments are itemized above. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating EBITDA and Adjusted EBITDA, you should be aware that in the future we may incur expenses that are the same or similar to some of the adjustments in the presentation. Our presentation of EBITDA and Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
